1. Spanish Ministry of Health. Current pandemic situation [Internet]. Current pandemic situation. 2020 [cited 2020 Dec 28]. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm
2. Omer SB, Yildirim I, Forman HP. Herd Immunity and Implications for SARS-CoV-2 Control. 2020; Available from: https://www.
3. Domingo P, Pomar V, Mur I, Castellví I, Corominas H, de Benito N. Not all COVID-19 pandemic waves are alike. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021 Apr;
4. Li X, Ma X. Acute respiratory failure in COVID-19: Is it “typical” ARDS? Crit Care. 2020;24(1):1–5.
5. Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, et al. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis. Bhatt GC, editor. PLoS One [Internet]. 2020 Nov 18 [cited 2020 Dec 1];15(11):e0241541. Available from: https://dx.plos.org/10.1371/journal.pone.0241541
6. Wu G, Yang P, Xie Y, Woodruff HC, Rao X, Guiot J, et al. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study. Available from: https://doi.org/10.1183/13993003.01104-2020
7. Cheng F-Y, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, et al. Clinical Medicine Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med [Internet]. 1668;2020:1668. Available from: www.mdpi.com/journal/jcm
8. Izquierdo JL, Ancochea J, Soriano JB, Soriano JB. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing. J Med Internet Res [Internet]. 2020 Oct 28 [cited 2021 Feb 15];22(10):e21801. Available from: http://www.jmir.org/2020/10/e21801/
9. Gupta RK, Harrison EM, Ho A, Docherty AB, Knight SR, van Smeden M, et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med [Internet]. 2021 Jan 11;2600(20). Available from: http://www.ncbi.nlm.nih.gov/pubmed/33444539
10. Barmaki R. Multimodal assessment of teaching behavior in immersive rehearsal environment - TeachLivETM. ICMI 2015 - Proc 2015 ACM Int Conf Multimodal Interact. 2015;139:651–5.
11. Rodríguez-Pérez R, Bajorath J. Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. J Comput Aided Mol Des [Internet]. 2020;34:1013–26. Available from: https://doi.org/10.1007/s10822-020-00314-0
12. Hosmer DW, Lemeshow S. Applied Logistic regression. Second. Noel A.C NIIJ, editor. New York; 2000. 1–375 p.
13. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;
14. Marshall JC, Murthy S, Diaz J, Adhikari N, Angus DC, Arabi YM, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–7.
15. Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. Lazzeri C, editor. PLoS One [Internet]. 2020 Nov 17 [cited 2020 Dec 1];15(11):e0241955. Available from: https://dx.plos.org/10.1371/journal.pone.0241955
16. Foy BH, Carlson JCT, Reinertsen E, Raimon ;, Valls PI, Roger B;, et al. Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection + Supplemental content CONCLUSIONS AND RELEVANCE Elevated RDW at the time of hospital admission and an increase in RDW during hospitaliza. JAMA Netw Open [Internet]. 2020;3(9):2022058. Available from: https://jamanetwork.com/
17. Ouyang SM, Zhu HQ, Xie YN, Zou ZS, Zuo HM, Rao YW, et al. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19. BMC Infect Dis. 2020;20(1):1–10.
18. Fan X, Liu Z, Miyata T, Dasarathy S, Rotroff DM, Wu X, et al. Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank. Gastroenterology. 2021;160(1):455-458.e5.
19. Plaze M, Attali D, Petit AC, Blatzer M, Simon-Loriere E, Vinckier F, et al. Repurposing chlorpromazine to treat COVID-19: The reCoVery study. Encephale. 2020;46(3):169–72.
20. Oddy C, Mccaul J, Keeling P, Allington J, Senn D, Soni N, et al. Pharmacological predictors of morbidity and mortality in COVID-19. Available from: www.icmje.org/coi_disclosure.pdf
21. Alberto J, Roman S, Cabezón Villalba G, Amat-Santos IJ, Dueñas C, Otero DL, et al. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiol J [Internet]. 2021;28(3):360–8. Available from: www.cardiologyjournal.org
22. Satici C, Demirkol MA, Sargin Altunok E, Gursoy B, Alkan M, Kamat S, et al. Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 Sep;98:84–9.
23. Bradley P, Frost F, Tharmaratnam K, Wootton DG. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ open Respir Res. 2020 Dec;7(1).